BPC-157 calculators

A 5 mg BPC-157 vial reconstituted with 2 mL of bacteriostatic water gives 2.5 mg/mL — the standard healing-research concentration. A 250 mcg dose pulls 0.1 mL or 10 units, leaving 19 doses in the vial. That's roughly a 3-week protocol per vial at daily injection.

One BPC-157-specific failure mode worth knowing before you use the reconstitution math: Reusing the previous vial's unit count after switching to a new vial reconstituted with a different volume. How many units of BPC-157 are in 250 mcg? On a 5 mg vial reconstituted with 2 mL of bacteriostatic water (2,500 mcg per mL), 250 mcg is exactly 10 units on a U-100 insulin syringe. On a 5 mg vial with 1 mL of BAC water, the same dose is 5 units.

Vial size, diluent volume, and dose are the three inputs that genuinely change the answer. Doses-per-vial is a derived output — it's the vial mg divided by the dose mg, rounded down. The most common edge case is a tiny dose: at very high concentration, a 0.1 mL draw is only a few units on the syringe, which is hard to read accurately. If your unit count drops below five, consider reconstituting the next vial with more BAC water so each dose covers a larger volume.

The illustrative example on this page assumes a 5 mg vial reconstituted with 2 mL of bacteriostatic water. That produces a concentration of 2.5 mg per mL, or 2,500 mcg per mL. A 250 mcg illustrative dose on that vial is 0.1 mL — exactly 10 units on a U-100 insulin syringe.

Because BPC-157 doses are small, choosing a sensible diluent volume matters. Less BAC water concentrates the solution and reduces the unit count per dose, which can be hard to read accurately at very small unit numbers. More BAC water produces cleaner, easier-to-read draws at the cost of slightly fewer total doses per vial.

The preparation method for BPC-157 can differ based on the administration route being documented, which adds a layer of complexity to the logging process. For subcutaneous injection, the standard procedure involves reconstituting the lyophilized powder with a sterile diluent like bacteriostatic water. However, research models that study oral administration describe a different preparation. In these published studies, the peptide is often dissolved directly into a measured volume of drinking water for consumption. Therefore, a comprehensive tracking log should not only record the dose and route but also the specific preparation method used, as this reflects a fundamental difference in how the compound is prepared for administration.